U.S. STOCKS Exact Sciences, Sezzle, Robinhood Markets
Eikon search string for individual stock moves: STXBZ
The Day Ahead newsletter: https://refini.tv/3LI4BU7
The Morning News Call newsletter: https://refini.tv/3dKUyB8
U.S. stock index futures slipped on Thursday as Treasury yields rose further ahead of jobless claims data that could provide a clearer picture of the Federal Reserve's interest rate agenda for the year. .N
At 7:38 ET, Dow e-minis 1YMc1 were down 0.18% at 39,126. S&P 500 e-minis ESc1 were down 0.14% at 5,205.25, while Nasdaq 100 e-minis NQc1 were down 0.19% at 18,152.
The top three NYSE percentage gainers premarket .PRPG.NQ:
** FiscalNote Holdings Inc <NOTE.K>, up 14.8%
** YETI Holdings Inc <YETI.K>, up 13.5%
** The Lion Electric Company <LEV>, up 11.6%
The top three NYSE percentage losers premarket .PRPL.NQ:
** EPAM Systems Inc <EPAM.K>, down 14.6%
** Stevanato Group SpA <STVN.K>, down 12.4%
** BGSF Inc <BGSF.K>, down 10.3%
The top three Nasdaq percentage gainers premarket .PRPG.O:
** Pop Culture Group Co Ltd <CPOP.O>, up 82.4%
** Sezzle Inc <SEZL.O>, up 45.3%
** Inspire Veterinary Partners Inc <IVP.O>, up 37.2%
The top two Nasdaq percentage losers premarket .PRPL.O:
** EMCORE Corp <EMKR.O>, down 36.6%
** Tivic Health Systems Inc <TIVC.O>, down 35.8%
** Sezzle Inc SEZL.O: up 45.3% premarket
BUZZ - Jumps on FY net income forecast lift nL4N3HC2HG
** Beyond Meat Inc BYND.O: down 12.9% premarket
BUZZ - Slumps on wider-than-expected loss, drop in sales nL4N3HC2IZ
** Vanda Pharmaceuticals Inc VNDA.O: down 6.5% premarket
BUZZ - Falls after posting Q1 loss nL4N3HC2JV
** Robinhood Markets Inc HOOD.O: up 5.1% premarket
BUZZ - Jumps after Q1 results sail past estimates nL4N3HC2JO
** Exact Sciences Corp EXAS.O: down 13.4% premarket
BUZZ - Falls on wider Q1 loss nL4N3HC2PD
** Tesla Inc TSLA.O: down 0.5% premarket
BUZZ - Dips after report of more job cuts in China nL4N3HC2PJ
** SNDL Inc SNDL.O: down 2.4% premarket
BUZZ - Falls after downbeat Q1 revenue nL4N3HC2UQ
** Tapestry Inc TPR.N: down 1.1% premarket
BUZZ - Cuts annual sales forecast after Q3 sales miss; shares fall nL4N3HC2WC
** EPAM Systems Inc EPAM.N: down 14.6% premarket
BUZZ - Falls after downbeat Q2 forecast on weak demand nL4N3HC2XP
** CytomX Therapeutics Inc CTMX.O: down 30.3% premarket
BUZZ - Slides on questions over cancer therapy's trial data nL4N3HC2XN
** Cheesecake Factory Inc CAKE.O: up 4.5% premarket
BUZZ - Rises on Q1 results beat nL4N3HC2XU
(Compiled by Rajarshi Roy and Kabir Dweit in Bengaluru)
</body></html>Related Assets
Latest News
Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.
All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.
Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.
